SIGN UPLog In

Last deal

$9M

Amount

Series A

Stage

20.06.2019

Date

2

all rounds

$11M

Total amount

General

About Company
Tangen Bioscience's instrument provides rapid nucleic acid detection without laboratory resources or skilled operators.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2013

Operating Status

Closed

Number of employees

1-10

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

Tangen Biosciences LLC develops medical instrument that provides rapid nucleic acid detection, with the specificity and sensitivity of polymerase chain reaction (PCR) amplification.
Contacts

location

Branford, CT, USA

Phone number

Website URL

http://tangenbio.com/